CASP1 and hepatocellular carcinoma: We also demonstrate that the pan-DPP inhibitory compound ARI-4175 significantly reduced the number of macroscopic liver nodules while increasing the abundance of CD8+ T cells and of activated caspase-1 in a DEN/TAA/HFD-induced HCC model in mice.